Q9HCD5 (NCOA5_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 88.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Nuclear receptor coactivator 5 Short name=NCoA-5 Alternative name(s): Coactivator independent of AF-2 Short name=CIA | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 579 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Nuclear receptor coregulator that can have both coactivator and corepressor functions. Interacts with nuclear receptors for steroids (ESR1 and ESR2) independently of the steroid binding domain (AF-2) of the ESR receptors, and with the orphan nuclear receptor NR1D2. Involved in the coactivation of nuclear steroid receptors (ER) as well as the corepression of MYC in response to 17-beta-estradiol (E2). Ref.2 |
| Subunit structure | Binds HTATIP2/TIP30. Interacts with YLPM1. Forms a complex with ILF2, ILF3, YLPM1, KHDRBS1, RBMX and PPP1CA. Ref.1 Ref.2 Ref.10 |
| Subcellular location | |
| Tissue specificity | Widely expressed. |
| Domain | Contains one Leu-Xaa-Xaa-Leu-Leu (LxxLL) motif that is essential for the association with nuclear receptors. |
| Sequence caution | The sequence AAG36793.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Transcription Transcription regulation |
| Cellular component | Nucleus |
| Coding sequence diversity | Polymorphism |
| Molecular function | Activator Repressor |
| PTM | Acetylation Phosphoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological process | regulation of transcription, DNA-dependent Inferred from electronic annotation. Source: UniProtKB-KW transcription, DNA-dependentInferred from electronic annotation. Source: UniProtKB-KW |
| Cellular component | nucleus Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | ATP binding Inferred from electronic annotation. Source: InterPro aminoacyl-tRNA ligase activityInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 579 | 579 | Nuclear receptor coactivator 5 | PRO_0000094411 | |||||||
Regions | |||||||||||
| Region | 1 – 158 | 158 | Transcription repression | ||||||||
| Region | 458 – 579 | 122 | Transcription activation | ||||||||
| Motif | 345 – 349 | 5 | LXXLL motif | ||||||||
| Compositional bias | 7 – 150 | 144 | Arg/Asp-rich (mixed charge) | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 1 | 1 | N-acetylmethionine Ref.13 | ||||||||
| Modified residue | 3 | 1 | Phosphothreonine Ref.13 | ||||||||
| Modified residue | 9 | 1 | Phosphoserine Ref.13 | ||||||||
| Modified residue | 29 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 34 | 1 | Phosphoserine By similarity | ||||||||
| Modified residue | 127 | 1 | Phosphotyrosine Ref.9 | ||||||||
| Modified residue | 151 | 1 | Phosphoserine Ref.9 | ||||||||
| Modified residue | 377 | 1 | Phosphoserine Ref.11 | ||||||||
| Modified residue | 378 | 1 | Phosphoserine Ref.12 Ref.14 | ||||||||
| Modified residue | 379 | 1 | Phosphothreonine Ref.13 Ref.14 | ||||||||
| Modified residue | 381 | 1 | Phosphoserine Ref.12 Ref.13 Ref.14 | ||||||||
| Modified residue | 387 | 1 | Phosphoserine Ref.11 | ||||||||
| Modified residue | 404 | 1 | Phosphoserine Ref.8 | ||||||||
| Modified residue | 420 | 1 | Phosphothreonine Ref.8 | ||||||||
Natural variations | |||||||||||
| Natural variant | 326 | 1 | E → G. Corresponds to variant rs11549557 [ dbSNP | Ensembl ]. | VAR_053530 | |||||||
Experimental info | |||||||||||
| Mutagenesis | 342 | 1 | I → A: Abolishes E2-inducible strong interaction with ESR1, but not basal interaction. Ref.1 | ||||||||
| Mutagenesis | 348 – 349 | 2 | LL → AA: Abolishes interaction with ESR1. | ||||||||
Secondary structure | |||||||||||
Helix Strand Turn | |||||||||||
| Helix | 345 – 350 | 6 | |||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant." Sauve F., McBroom L.D.B., Gallant J., Moraitis A.N., Labrie F., Giguere V. Mol. Cell. Biol. 21:343-353(2001) [PubMed: 11113208] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH ESR1; ESR2 AND NR1D2, MUTAGENESIS OF ILE-342 AND 348-LEU-LEU-349. Tissue: Fetal kidney. |
| [2] | "TIP30 interacts with an estrogen receptor alpha-interacting coactivator CIA and regulates c-myc transcription." Jiang C., Ito M., Piening V., Bruck K., Roeder R.G., Xiao H. J. Biol. Chem. 279:27781-27789(2004) [PubMed: 15073177] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 86-91 AND 280-292, FUNCTION, INTERACTION WITH HTATIP2. |
| [3] | "The DNA sequence and comparative analysis of human chromosome 20." Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R., Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L., Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P., Bird C.P., Blakey S.E. Rogers J.Nature 414:865-871(2001) [PubMed: 11780052] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [6] | "Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro." Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O. DNA Res. 7:273-281(2000) [PubMed: 10997877] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 101-579. Tissue: Brain. |
| [7] | "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones." Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T. DNA Res. 9:99-106(2002) [PubMed: 12168954] [Abstract] Cited for: SEQUENCE REVISION. |
| [8] | "Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry." Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J., Bodenmiller B., Watts J.D., Hood L., Aebersold R. Nat. Methods 2:591-598(2005) [PubMed: 16094384] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-404 AND THR-420, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [9] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-127 AND SER-151, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "The nuclear PP1 interacting protein ZAP3 (ZAP) is a putative nucleoside kinase that complexes with SAM68, CIA, NF110/45, and HNRNP-G." Ulke-Lemee A., Trinkle-Mulcahy L., Chaulk S., Bernstein N.K., Morrice N., Glover M., Lamond A.I., Moorhead G.B.G. Biochim. Biophys. Acta 1774:1339-1350(2007) [PubMed: 17890166] [Abstract] Cited for: IDENTIFICATION IN A COMPLEX WITH ILF2; ILF3; YLPM1; KHDRBS1; RBMX AND PPP1CA, INTERACTION WITH YLPM1. |
| [11] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377 AND SER-387, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [12] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378 AND SER-381, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-3; SER-9; THR-379 AND SER-381, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [14] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378; THR-379 AND SER-381, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [15] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [16] | "Solution structure of anticodon binding domain from nuclear receptor coactivator 5 (human KIAA1637 protein)." RIKEN structural genomics initiative (RSGI) Submitted (JUL-2004) to the PDB data bank Cited for: STRUCTURE BY NMR OF 197-313. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF230533 mRNA. Translation: AAG36793.1. Different initiation. AF470686 mRNA. Translation: AAO33457.1. AL035662, AL162458 Genomic DNA. Translation: CAI42972.1. AL162458, AL035662 Genomic DNA. Translation: CAH74052.1. CH471077 Genomic DNA. Translation: EAW75765.1. CH471077 Genomic DNA. Translation: EAW75769.1. BC140836 mRNA. Translation: AAI40837.1. BC151133 mRNA. Translation: AAI51134.1. AB046857 mRNA. Translation: BAB13463.1. | ||||||||||||||||||||||||
| IPI | IPI00288941. | ||||||||||||||||||||||||
| RefSeq | NP_066018.1. NM_020967.2. | ||||||||||||||||||||||||
| UniGene | Hs.654991. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||||||||
| ProteinModelPortal | Q9HCD5. | ||||||||||||||||||||||||
| SMR | Q9HCD5. Positions 197-314. | ||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||||||||
| IntAct | Q9HCD5. 3 interactions. | ||||||||||||||||||||||||
| STRING | Q9HCD5. | ||||||||||||||||||||||||
PTM databases | |||||||||||||||||||||||||
| PhosphoSite | Q9HCD5. | ||||||||||||||||||||||||
Polymorphism databases | |||||||||||||||||||||||||
| DMDM | 28380083. | ||||||||||||||||||||||||
Proteomic databases | |||||||||||||||||||||||||
| PRIDE | Q9HCD5. | ||||||||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||||||||
Genome annotation databases | |||||||||||||||||||||||||
| Ensembl | ENST00000290231; ENSP00000290231; ENSG00000124160. | ||||||||||||||||||||||||
| GeneID | 57727. | ||||||||||||||||||||||||
| KEGG | hsa:57727. | ||||||||||||||||||||||||
| UCSC | uc002xrd.1. human. | ||||||||||||||||||||||||
Organism-specific databases | |||||||||||||||||||||||||
| CTD | 57727. | ||||||||||||||||||||||||
| GeneCards | GC20M044690. | ||||||||||||||||||||||||
| H-InvDB | HIX0015876. | ||||||||||||||||||||||||
| HGNC | HGNC:15909. NCOA5. | ||||||||||||||||||||||||
| neXtProt | NX_Q9HCD5. | ||||||||||||||||||||||||
| PharmGKB | PA31474. | ||||||||||||||||||||||||
| HUGE | Search... | ||||||||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| GeneTree | ENSGT00530000064134. | ||||||||||||||||||||||||
| HOGENOM | HBG713301. | ||||||||||||||||||||||||
| HOVERGEN | HBG052585. | ||||||||||||||||||||||||
| InParanoid | Q9HCD5. | ||||||||||||||||||||||||
| OMA | LMRSSTD. | ||||||||||||||||||||||||
| OrthoDB | EOG42BX8N. | ||||||||||||||||||||||||
| PhylomeDB | Q9HCD5. | ||||||||||||||||||||||||
Gene expression databases | |||||||||||||||||||||||||
| ArrayExpress | Q9HCD5. | ||||||||||||||||||||||||
| Bgee | Q9HCD5. | ||||||||||||||||||||||||
| CleanEx | HS_NCOA5. | ||||||||||||||||||||||||
| Genevestigator | Q9HCD5. | ||||||||||||||||||||||||
| GermOnline | ENSG00000124160. Homo sapiens. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR004154. Anticodon-bd. [Graphical view] | ||||||||||||||||||||||||
| Gene3D | G3DSA:3.40.50.800. Anticodon_bd. 1 hit. | ||||||||||||||||||||||||
| SUPFAM | SSF52954. Anticodon_bd. 1 hit. | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Other | |||||||||||||||||||||||||
| NextBio | 64672. | ||||||||||||||||||||||||
| PMAP-CutDB | Q9HCD5. | ||||||||||||||||||||||||
Entry information
| Entry name | NCOA5_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9HCD5 Secondary accession number(s): B2RTV9 Q9H4Y9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 20 Human chromosome 20: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |

Clusters with